Mr. Milinazzo has 15 years of experience in interventional cardiology, and will replace Ofir Paz, who announced his plans to step down in September.
Formerly, Mr. Milinazzo was the president and CEO of Orthofix International, where he worked with spine devices and orthopedic stem cell therapy.
More Articles on Devices:
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
